CYRX — Cryoport, Inc.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1124524 ·
Last close
$19.74
Market Cap
$999.81M
52W High
$21.78
52W Low
$7.61
ADV30
1,092,797
Next earnings
2026-11-05
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | 50,220,000 | 23,834,000 | -8,804,000 | -10,852,000 | 750,945,000 | 279,179,000 | 267,431,000 |
| Jun 2026 | 48,971,000 | 22,824,000 | -10,039,000 | -8,255,000 | 756,204,000 | 269,267,000 | 265,505,000 |
| Mar 2026 | 47,798,000 | 21,913,000 | -9,614,000 | -10,544,000 | 763,609,000 | 272,912,000 | 268,620,000 |
| Dec 2025 | 45,450,000 | 21,711,000 | -10,031,000 | -11,644,000 | 764,989,000 | 250,494,000 | 262,351,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$7,973,000
Investing CF
$27,267,000
Financing CF
$-4,283,000
CapEx
$-29,321,000
Dividends Paid
—
Buybacks
$-5,752,000
EPS Diluted TTM
$-0.90
As of
2026-11-08
Balance + Analyst (yfinance extras)
Retained Earnings
$-707,683,000
Inventory
$21,506,000
Receivables
$36,454,000
ST Investments
$127,426,000
EBIT TTM
$-28,890,000
Pretax Income TTM
$-31,000,000
Interest Exp TTM
$2,110,000
Analysts
9
Yahoo Snapshot (yfinance, live)
Total Revenue
$192,439,008
EBITDA
$-4,629,000
Free Cash Flow
$-14,678,000
Enterprise Value
$805,926,144
Total Cash
$393,076,000
Total Debt
$231,511,008
Shares Out
50,649,100
Trailing EPS
$-0.90
Book Value
$9.54
ROE
-7.4%
ROA
-2.7%
Div Yield
0.00%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 176,177,000 | -36,806,000 | 78,301,000 | 764,989,000 | 262,351,000 | 502,638,000 | -8,580,000 |
| Dec 2024 | 156,769,000 | -57,862,000 | -114,756,000 | 703,492,000 | 301,594,000 | 401,898,000 | -16,323,000 |
| Dec 2023 | 168,662,000 | -50,968,000 | -99,587,000 | 957,744,000 | 468,721,000 | 489,023,000 | -757,000 |
| Dec 2022 | 237,277,000 | -31,904,000 | -37,333,000 | 1,038,746,000 | 482,908,000 | 555,838,000 | -1,851,000 |
TTM Snapshot
Revenues TTM
$186,452,000
NetIncome TTM
$-33,697,000
OpCashFlow TTM
—
Assets (Latest)
$756,204,000
Forward EPS
$-0.66
Max Pain — expiry 2026-12-18
max pain strike: $17.50 · spot: $20.17 · call oi: 9,665 · put oi: 1,128
Expected Move to 2026-12-18:
±$2.56
(12.69%) —
implied range
$17.61 –
$22.73
· ATM straddle on $20.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| ANRO | Alto Neuroscience, Inc. | $999.16M | $24.91 | — |
| OMER | OMEROS CORP | $1.01B | $13.92 | — |
| SVRA | Savara Inc | $988.39M | $4.48 | — |
| MTRI | InMed Pharmaceuticals Inc. | $1.02B | $17.50 | — |
| JBIO | Jade Biosciences, Inc. | $979.40M | $15.40 | — |
News headlines (Yahoo Finance, 1h cache)
Cryoport (CYRX) Stock Looks Fully Priced Following Its 129% Rebound
2026-11-13 15:14 · Yahoo
Why Cryoport (CYRX) Shares Climbed After Its Latest Update?
2026-11-10 21:14 · Yahoo
What Comes Next For Cryoport After A 100% Gain
2026-11-09 20:06 · Yahoo
Cryoport, Inc. Q3 2026 Earnings Call Summary
2026-11-06 13:30 · Yahoo
Cryoport (CYRX) Q3 2026 Earnings Call Transcript
2026-11-06 08:14 · Yahoo
CryoPort Inc (CYRX) (Q3 2026) Earnings Call Highlights: Record Clinical Pipeline and Positive ...
2026-11-06 05:23 · Yahoo
CryoPort Q3 Earnings Call Highlights
2026-11-06 05:14 · Yahoo
CryoPort, Inc. (CYRX) Reports Q3 Loss, Tops Revenue Estimates
2026-11-05 21:45 · Yahoo
Cryoport Reports Third Quarter 2026 Financial Results
2026-11-05 21:05 · Yahoo
Cryoport to Report Third Quarter 2026 Financial Results on November 5, 2026
2026-10-22 12:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.